HTFL.NASDAQHeartflow, INC

Form 4: Heartflow CMO Reports Routine Tax-Related Stock Sale

Sentiment:

Statement of Changes in Beneficial Ownership


Chief Medical Officer Campbell Rogers disposed of 2,271 shares of Heartflow, Inc. common stock to satisfy tax withholding obligations.

Summary

  • Campbell Rogers, Chief Medical Officer of Heartflow, Inc., executed a net settlement of restricted stock units.
  • A total of 1,634 shares were withheld on 05/06/2026 at a price of $30.29 per share.
  • An additional 637 shares were withheld on 05/07/2026 at a price of $29.98 per share.
  • The transactions were conducted to satisfy mandatory income tax withholding obligations related to the vesting of equity awards.
  • Following these transactions, the reporting person maintains direct ownership of 78,731 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transaction is purely administrative and related to tax compliance rather than a discretionary sale of stock.

Positives

  • The transaction was a non-discretionary event related to tax compliance rather than a market-based sale.
  • The reporting person retains significant beneficial ownership through various trusts, totaling 145,540 indirect shares.

Negatives

  • The filing reflects a reduction in the direct shareholding of a key executive.

Risks

  • None identified; this is a standard administrative filing for tax withholding.

Future Outlook

No forward-looking guidance provided in this filing.

Industry Context

StockSavvy.ai notes that net settlement transactions are standard industry practice for executives to manage tax liabilities associated with equity compensation vesting, and they generally do not signal a change in management sentiment regarding company performance.

Comparison to Industry Standards

  • The use of net settlement for tax obligations is a standard corporate governance practice among U.S. publicly traded medical technology companies.
  • The reporting structure involving multiple trusts is consistent with high-net-worth executive financial planning.

Stakeholder Impact

  • Minimal impact on shareholders as the transaction was a mandatory tax settlement.

Next Steps

  • None indicated.

Key Dates

DateDescription
05/06/2026Transaction date for the first tranche of shares withheld.
05/07/2026Transaction date for the second tranche of shares withheld.
05/08/2026Date of filing.

Keywords

Heartflow, HTFL, Insider Trading, Form 4, Equity Compensation, Tax Withholding

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.